| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |